The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $84.7692.
COO has been the subject of a number of research reports. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the company a “sell” rating in a research note on Wednesday, October 1st. Barclays began coverage on shares of Cooper Companies in a research note on Monday, October 13th. They set an “overweight” rating and a $85.00 target price for the company. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the stock an “equal weight” rating in a research report on Thursday, August 28th. Wells Fargo & Company dropped their target price on Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Finally, Wall Street Zen cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th.
Get Our Latest Report on Cooper Companies
Insiders Place Their Bets
Institutional Investors Weigh In On Cooper Companies
Hedge funds and other institutional investors have recently modified their holdings of the stock. Zions Bancorporation National Association UT purchased a new stake in shares of Cooper Companies in the 1st quarter worth $33,000. GKV Capital Management Co. Inc. purchased a new stake in shares of Cooper Companies in the 1st quarter worth $40,000. J.Safra Asset Management Corp increased its stake in shares of Cooper Companies by 204.8% in the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after purchasing an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies in the 2nd quarter worth $36,000. Finally, MUFG Securities EMEA plc purchased a new stake in shares of Cooper Companies in the 2nd quarter worth $42,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Cooper Companies Price Performance
Shares of NASDAQ COO opened at $69.08 on Wednesday. Cooper Companies has a twelve month low of $61.78 and a twelve month high of $107.84. The firm has a market cap of $13.73 billion, a P/E ratio of 34.03, a PEG ratio of 1.83 and a beta of 1.02. The company has a 50 day moving average of $69.20 and a 200 day moving average of $72.81. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the business earned $0.96 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, research analysts expect that Cooper Companies will post 3.98 EPS for the current fiscal year.
Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its stock is undervalued.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Read More
- Five stocks we like better than Cooper Companies
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- How to Invest in Insurance Companies: A Guide
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
